FIGURE

Fig. 11

ID

ZDB-FIG-250710-53

Publication

Sang et al., 2025 - Discovery of novel butyrylcholinesterase inhibitors for treating Alzheimer's disease

Other Figures

All Figure Page

Back to All Figure Page

Fig. 11

The mechanism of action of 8e. (A–G) The expression of identified differentially expressed proteins (Pfdn1, Ace, Dao, Vldlr, Yes1, Arg1, and Pdk1) closely related to the progression of AD. (H) The expressions of pfdn1 and VLDLR in cerebral cortex were determined by qPCR. (I) The expressions of pfdn1 and VLDLR in cerebral cortex were detected by Western blot. (J) The schematic diagram of the possible mechanism of action for compound 8e. Values are presented as mean ± SD from three independent experiments. #P < 0.05, ##P < 0.01, ###P < 0.001 vs. control group; ∗P < 0.05, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001 vs. model group.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Acta Pharm Sin B